Treatment For Bone Diseases

Patent No. EP2869844 (titled "Treatment For Bone Diseases") was filed by UCB Pharma on Jul 3, 2013. The application was issued on Jun 21, 2023.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
JAMES POOLE	Sep 18, 2020	CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

May 25, 2023
Decision to maintain the European patent in amended form
May 19, 2023
Termination of the opposition proceedings with maintenance of patent
May 10, 2023
(Electronic) Receipt
May 10, 2023
Filing of the translation of the amended claims
May 10, 2023
French translation of claims
May 10, 2023
German translation of the claims
May 10, 2023
Letter accompanying subsequently filed items
Feb 8, 2023
Communication of bibliographic data
Feb 8, 2023
Communication with request to file translations
Jan 31, 2023
Maintenance of the patent with the documents specified in the final decision
Sep 30, 2022
(Electronic) Receipt
Sep 30, 2022
Advice of delivery
Sep 30, 2022
Letter accompanying subsequently filed items
Sep 28, 2022
Decision of the Opposition Division and instruction
Sep 28, 2022
Druckexemplar in opposition procedure
Sep 28, 2022
Grounds for the decision (Annex) - opposition
Sep 28, 2022
Interlocutory decision in opposition proceedings
Sep 28, 2022
Means of redress
Sep 28, 2022
Transmittal of decision / summons - opposition
Apr 26, 2022
Brief communication - Opposition proceedings
Apr 26, 2022
Notification concerning the date of oral proceedings
Mar 30, 2022
(Electronic) Receipt
Mar 30, 2022
Amended description with annotations
Mar 30, 2022
Description
Mar 30, 2022
Letter accompanying subsequently filed items
Mar 30, 2022
Main request during Opposition procedure
Mar 30, 2022
Main request during Opposition procedure
Mar 30, 2022
Written submission in preparation to/during oral proceedings
Mar 15, 2022
Brief communication - Opposition proceedings
Mar 15, 2022
Brief communication - Opposition proceedings
Mar 9, 2022
(Electronic) Receipt
Mar 9, 2022
Letter accompanying subsequently filed items
Mar 9, 2022
Withdrawal of an opposition
Dec 8, 2021
Notification concerning the date of oral proceedings
Dec 8, 2021
Notification concerning the date of oral proceedings
Nov 10, 2021
Advice of delivery
Nov 9, 2021
(Electronic) Receipt
Nov 9, 2021
Advice of delivery
Nov 9, 2021
Letter accompanying subsequently filed items
Nov 8, 2021
Annex to the communication - opposition
Nov 8, 2021
Information concerning oral proceedings
Nov 8, 2021
Summons to attend oral proceedings
Nov 8, 2021
Summons to attend oral proceedings
Nov 8, 2021
Transmittal of decision / summons - opposition
Nov 8, 2021
Transmittal of decision / summons - opposition
Feb 18, 2021
Brief communication - Opposition proceedings
Feb 12, 2021
(Electronic) Receipt
Feb 12, 2021
Any annexes (other than citation) to an opposition letter
Feb 12, 2021
Citation in opposition procedure - 011
Feb 12, 2021
Citation in opposition procedure - 012
Feb 12, 2021
Citation in opposition procedure - 013
Feb 12, 2021
Citation in opposition procedure - 014
Feb 12, 2021
Citation in opposition procedure - 015
Feb 12, 2021
Citation in opposition procedure - 016
Feb 12, 2021
Citation in opposition procedure - 017
Feb 12, 2021
Citation in opposition procedure - 018
Feb 12, 2021
Citation in opposition procedure - 019
Feb 12, 2021
Citation in opposition procedure - 020
Feb 12, 2021
Citation in opposition procedure - 021
Feb 12, 2021
Citation in opposition procedure - 022
Feb 12, 2021
Citation in opposition procedure - 023
Feb 12, 2021
Citation in opposition procedure - 024
Feb 12, 2021
Citation in opposition procedure - 025
Feb 12, 2021
Citation in opposition procedure - 026
Feb 12, 2021
Citation in opposition procedure - 027
Feb 12, 2021
Consolidated list of cited opposition documents
Feb 12, 2021
Letter accompanying subsequently filed items
Feb 12, 2021
Reply of the patent proprietor to the notice(s) of opposition
Feb 12, 2021
Reply of the patent proprietor to the notice(s) of opposition
Oct 2, 2020
Communication of a notice of opposition and request to file observations
Oct 2, 2020
Notice of further oppositions to opponent(s)
Sep 24, 2020
Communication of a notice of opposition - first information to patent proprietor
Sep 18, 2020
(Electronic) Receipt
Sep 18, 2020
Citation in opposition procedure - 001
Sep 18, 2020
Citation in opposition procedure - 002
Sep 18, 2020
Citation in opposition procedure - 003
Sep 18, 2020
Citation in opposition procedure - 004
Sep 18, 2020
Citation in opposition procedure - 005
Sep 18, 2020
Citation in opposition procedure - 006
Sep 18, 2020
Citation in opposition procedure - 007
Sep 18, 2020
Citation in opposition procedure - 008
Sep 18, 2020
Citation in opposition procedure - 009
Sep 18, 2020
Citation in opposition procedure - 010
Sep 18, 2020
Notice of opposition
Sep 18, 2020
Notice of opposition
Jan 2, 2020
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Nov 21, 2019
Decision to grant a European patent
Nov 8, 2019
(Electronic) Receipt
Nov 8, 2019
Filing of the translations of the claims
Nov 8, 2019
French translation of claims
Nov 8, 2019
German translation of the claims
Nov 8, 2019
Letter accompanying subsequently filed items
Jul 5, 2019
Annex to the communication about intention to grant a European patent
Jul 5, 2019
Annex to the communication about intention to grant a European patent
Jul 5, 2019
Bibliographic data of the European patent application
Jul 5, 2019
Communication about intention to grant a European patent
Jul 5, 2019
Intention to grant (signatures)
Jul 5, 2019
Text intended for grant (clean copy)
Jul 5, 2019
Text intended for grant (version for approval)
Jun 19, 2019
Annex to a communication
Jun 19, 2019
Annex to a communication
Jun 19, 2019
Annex to a communication
Jun 19, 2019
Annex to a communication
Jun 19, 2019
Annex to the communication
Jun 19, 2019
Minutes of the oral proceedings (examining division)
Jun 19, 2019
Minutes of the oral proceedings (examining division)
Jun 19, 2019
Minutes of the oral proceedings (examining division)
Jun 19, 2019
Provision of a copy of the minutes of oral proceedings
Apr 9, 2019
(Electronic) Receipt
Apr 9, 2019
Amended claims with annotations
Apr 9, 2019
Amended claims with annotations
Apr 9, 2019
Amended claims with annotations
Apr 9, 2019
Amended claims with annotations
Apr 9, 2019
Amended claims with annotations
Apr 9, 2019
Amended claims with annotations
Apr 9, 2019
Amended claims with annotations
Apr 9, 2019
Amended claims with annotations
Apr 9, 2019
Amended claims with annotations
Apr 9, 2019
Claims
Apr 9, 2019
Claims
Apr 9, 2019
Claims
Apr 9, 2019
Claims
Apr 9, 2019
Claims
Apr 9, 2019
Claims
Apr 9, 2019
Claims
Apr 9, 2019
Claims
Apr 9, 2019
Claims
Apr 9, 2019
Letter accompanying subsequently filed items
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
Non-patent literature cited during the examination procedure
Apr 9, 2019
RO101 Declaration
Apr 9, 2019
Written submission in preparation to/during oral proceedings
Nov 6, 2018
(Electronic) Receipt
Nov 6, 2018
Advice of delivery
Nov 6, 2018
Letter accompanying subsequently filed items
Oct 31, 2018
Annex to the communication
Oct 31, 2018
Preparation for oral proceedings
Oct 31, 2018
Summons to attend oral proceedings
Feb 1, 2018
(Electronic) Receipt
Feb 1, 2018
Amended claims with annotations
Feb 1, 2018
Claims
Feb 1, 2018
Description
Feb 1, 2018
Letter accompanying subsequently filed items
Feb 1, 2018
Non-patent literature cited during the examination procedure
Feb 1, 2018
Non-patent literature cited during the examination procedure
Feb 1, 2018
Reply to communication from the Examining Division
Dec 6, 2017
Grant of extension of time limit (examination procedure)
Dec 1, 2017
(Electronic) Receipt
Dec 1, 2017
Letter accompanying subsequently filed items
Dec 1, 2017
Request for extension of time limit to communication from the Examining Division
Aug 2, 2017
Annex to the communication
Aug 2, 2017
Communication from the Examining Division
Jul 27, 2017
Examination started
Jun 12, 2017
Communication of amended entries concerning the representative
Jun 7, 2017
Submission concerning change of applicant's representative
Jun 6, 2017
Submission concerning change of applicant's representative
Apr 18, 2017
Notification regarding date of start of examination with possibility to withdraw
Oct 9, 2015
(Electronic) Receipt
Oct 9, 2015
Amended claims filed after receipt of (European) search report
Oct 9, 2015
Amended claims with annotations
Oct 9, 2015
Amendments received before examination
Oct 9, 2015
Letter accompanying subsequently filed items
Apr 15, 2015
Notification on forthcoming publication of bibliographic data
Mar 31, 2015
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
Mar 3, 2015
Communication to designated inventor
Jan 27, 2015
(Electronic) Receipt
Jan 27, 2015
Annex
Jan 27, 2015
Request for entry into the European phase
Jan 20, 2015
Copy of the international preliminary report on patentability
Nov 14, 2014
Information on entry into European phase
Jan 28, 2014
Priority document (electronically transmitted)
Jan 28, 2014
Priority document (electronically transmitted)
Jan 9, 2014
Converted Sequence Listing
Jan 9, 2014
Copy of the international search report
Jan 9, 2014
Published international application - A1
Oct 22, 2013
Written opinion of the ISA, boxes No. I to VIII
Oct 22, 2013
Written opinion of the ISA, cover sheet
Oct 22, 2013
Written opinion of the ISA, supplemental box
Jul 3, 2013
(Electronic) Receipt
Jul 3, 2013
Abstract
Jul 3, 2013
Claims
Jul 3, 2013
Description
Jul 3, 2013
Drawings

EP2869844

UCB PHARMA

Application Number: EP13733322A
Filing Date: Jul 3, 2013
Status: Patent Maintained As Amended; May 19, 2023
Publication Date: Jun 21, 2023
External Links: Slate, Register , Google Patents

IP Verse

Treatment For Bone Diseases

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2869844